|
Cell-Free Expression for Nanolipoprotein Particles: Building a High-Throughput Membrane Protein Solubility Platform
|
book
|
January 2009 |
|
Atomic force microscopy differentiates discrete size distributions between membrane protein containing and empty nanolipoprotein particles
|
journal
|
March 2009 |
|
Quantifying Interactions of a Membrane Protein Embedded in a Lipid Nanodisc using Fluorescence Correlation Spectroscopy
|
journal
|
January 2014 |
|
Amino acid and structural variability of Yersinia pestis LcrV protein
|
journal
|
January 2010 |
|
Minimal YopB and YopD translocator secretion by Yersinia is sufficient for Yop-effector delivery into target cells
|
journal
|
February 2007 |
|
Yersinia pestis YopD 150–287 fragment is partially unfolded in the native state
|
journal
|
March 2008 |
|
Type III secretion gets an LcrV tip
|
journal
|
May 2006 |
|
A bilayer cell-free protein synthesis system for high-throughput screening of gene products
|
journal
|
February 2002 |
|
Different Apolipoproteins Impact Nanolipoprotein Particle Formation
|
journal
|
November 2007 |
|
Hydrogen Production by a Hyperthermophilic Membrane-Bound Hydrogenase in Water-Soluble Nanolipoprotein Particles
|
journal
|
June 2009 |
|
Insertion of Membrane Proteins into Discoidal Membranes Using a Cell-Free Protein Expression Approach
|
journal
|
August 2008 |
|
The type III secretion injectisome
|
journal
|
November 2006 |
|
YopD of Yersinia pseudotuberculosis is translocated into the cytosol of HeLa epithelial cells: evidence of a structural domain necessary for translocation
|
journal
|
August 1998 |
|
The Salmonella type III secretion translocon protein SspC is inserted into the epithelial cell plasma membrane upon infection
|
journal
|
September 2000 |
|
LcrV is a channel size-determining component of the Yop effector translocon of Yersinia
|
journal
|
February 2001 |
|
Type III export: new uses for an old pathway
|
journal
|
April 2001 |
|
Cell-free Co-expression of Functional Membrane Proteins and Apolipoprotein, Forming Soluble Nanolipoprotein Particles
|
journal
|
July 2008 |
|
Protective Anti‐V Antibodies Inhibit Pseudomonas and Yersinia Translocon Assembly within Host Membranes
|
journal
|
July 2005 |
|
The V-Antigen of Yersinia Forms a Distinct Structure at the Tip of Injectisome Needles
|
journal
|
October 2005 |
|
Supramolecular Structure of the Salmonella typhimurium Type III Protein Secretion System
|
journal
|
April 1998 |
|
Vaccination of Mice with a Yop Translocon Complex Elicits Antibodies That Are Protective against Infection with F1- Yersinia pestis
|
journal
|
September 2008 |
|
YopB and YopD constitute a novel class of Yersinia Yop proteins.
|
journal
|
January 1993 |
|
Immune Response to Yersinia Outer Proteins and Other Yersinia pestis Antigens after Experimental Plague Infection in Mice
|
journal
|
April 1999 |
|
Interleukin-10 and Inhibition of Innate Immunity to Yersiniae: Roles of Yops and LcrV (V Antigen)
|
journal
|
July 2003 |
|
Role of Predicted Transmembrane Domains for Type III Translocation, Pore Formation, and Signaling by the Yersinia pseudotuberculosis YopB Protein
|
journal
|
March 2005 |
|
The YopD Translocator of Yersinia pseudotuberculosis Is a Multifunctional Protein Comprised of Discrete Domains
|
journal
|
June 2004 |
|
Characterizing diffusion dynamics of a membrane protein associated with nanolipoproteins using fluorescence correlation spectroscopy
|
journal
|
January 2011 |
|
Cell-Free Expression for Nanolipoprotein Particles: Building a High-Throughput Membrane Protein Solubility Platform
|
book
|
January 2009 |
|
The difference in the IcrV sequences between Y. pestis and Y. pseudotuberculosis and its application for characterization of Y. pseudotuberculosis strains
|
journal
|
March 1992 |
|
A bilayer cell-free protein synthesis system for high-throughput screening of gene products
|
journal
|
February 2002 |
|
Atomic force microscopy differentiates discrete size distributions between membrane protein containing and empty nanolipoprotein particles
|
journal
|
March 2009 |
|
Quantifying Interactions of a Membrane Protein Embedded in a Lipid Nanodisc using Fluorescence Correlation Spectroscopy
|
journal
|
January 2014 |
|
Amino acid and structural variability of Yersinia pestis LcrV protein
|
journal
|
January 2010 |
|
Minimal YopB and YopD translocator secretion by Yersinia is sufficient for Yop-effector delivery into target cells
|
journal
|
February 2007 |
|
Yersinia pestis YopD 150–287 fragment is partially unfolded in the native state
|
journal
|
March 2008 |
|
Type III secretion gets an LcrV tip
|
journal
|
May 2006 |
|
Different Apolipoproteins Impact Nanolipoprotein Particle Formation
|
journal
|
November 2007 |
|
Hydrogen Production by a Hyperthermophilic Membrane-Bound Hydrogenase in Water-Soluble Nanolipoprotein Particles
|
journal
|
June 2009 |
|
Insertion of Membrane Proteins into Discoidal Membranes Using a Cell-Free Protein Expression Approach
|
journal
|
August 2008 |
|
Laboratory scale structural genomics
|
journal
|
March 2004 |
|
The type III secretion injectisome
|
journal
|
November 2006 |
|
YopD of Yersinia pseudotuberculosis is translocated into the cytosol of HeLa epithelial cells: evidence of a structural domain necessary for translocation
|
journal
|
August 1998 |
|
The Salmonella type III secretion translocon protein SspC is inserted into the epithelial cell plasma membrane upon infection
|
journal
|
September 2000 |
|
LcrV is a channel size-determining component of the Yop effector translocon of Yersinia
|
journal
|
February 2001 |
|
Type III export: new uses for an old pathway
|
journal
|
April 2001 |
|
Conformational analysis by CD and NMR spectroscopy of a peptide encompassing the amphipathic domain of YopD from Yersinia : Tertiary structure of the YopD amphipathic domain
|
journal
|
July 2002 |
|
Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis
|
journal
|
September 2004 |
|
Protective Anti‐V Antibodies Inhibit Pseudomonas and Yersinia Translocon Assembly within Host Membranes
|
journal
|
July 2005 |
|
Yersinia enterocolitica type III secretion-translocation system: channel formation by secreted Yops
|
journal
|
December 1999 |
|
Immune defense against pneumonic plague
|
journal
|
October 2008 |
|
Cell-free expression as an emerging technique for the large scale production of integral membrane protein
|
journal
|
September 2006 |
|
The V-Antigen of Yersinia Forms a Distinct Structure at the Tip of Injectisome Needles
|
journal
|
October 2005 |
|
Supramolecular Structure of the Salmonella typhimurium Type III Protein Secretion System
|
journal
|
April 1998 |
|
Vaccination of Mice with a Yop Translocon Complex Elicits Antibodies That Are Protective against Infection with F1- Yersinia pestis
|
journal
|
September 2008 |
|
YopB and YopD constitute a novel class of Yersinia Yop proteins.
|
journal
|
January 1993 |
|
Protective Efficacy of RecombinantYersinia Outer Proteins against Bubonic Plague Caused by Encapsulated and Nonencapsulated Yersinia pestis
|
journal
|
March 1999 |
|
Immune Response to Yersinia Outer Proteins and Other Yersinia pestis Antigens after Experimental Plague Infection in Mice
|
journal
|
April 1999 |
|
Interleukin-10 and Inhibition of Innate Immunity to Yersiniae: Roles of Yops and LcrV (V Antigen)
|
journal
|
July 2003 |
|
Role of Predicted Transmembrane Domains for Type III Translocation, Pore Formation, and Signaling by the Yersinia pseudotuberculosis YopB Protein
|
journal
|
March 2005 |
|
The YopD Translocator of Yersinia pseudotuberculosis Is a Multifunctional Protein Comprised of Discrete Domains
|
journal
|
June 2004 |